We’re proud to be part of such a tight-knit community. The more we can stay in touch, the closer we can work together. Click subscribe to receive news and updates about Amylyx.
Functional and Survival Benefit of Sodium Phenylbutyrate–Taurursodiol in Amyotrophic Lateral Sclerosis
Lead Author: Sabrina Paganoni, MD, PhD
Published: International Congress on Neuromuscular Diseases (ICNMD)
Date: May 21 - 22, 2021 & May 28 - 29, 2021
Design of the International, Randomized, Placebo-Controlled Phase 3 PHOENIX Trial of AMX0035 in Amyotrophic Lateral Sclerosis
Lead Author: Leonard H. van den Berg, MD, PhD
Published: European Network to Cure ALS (ENCALS)
Date: May 12 - 14, 2021
Long-Term Survival of Participants in the CENTAUR Trial of AMX0035 for ALS
Lead Author: Sabrina Paganoni, MD, PhD
Published: American Academy of Neurology (AAN)
Date: April 19, 2021
Lower Long-Term Risk of Death or Permanent Ventilation and First Hospitalization Among Participants with ALS Receiving AMX0035 in the CENTAUR Trial
Lead Author: Sabrina Paganoni, MD, PhD
Published: Muscular Dystrophy Association (MDA)
Date: March 18, 2021
Functional and Long-Term Survival Data of AMX0035 in Amyotrophic Lateral Sclerosis: Results of the CENTAUR Trial
Lead Author: Sabrina Paganoni, MD, PhD
Published: American Society for Experimental Neurotherapeutics (ASENT)
Date: February 23, 2021
Functional and Long-Term Survival Benefit of AMX0035 in ALS: Results of the CENTAUR and Open-Label Extension Trials
Lead Author: Sabrina Paganoni, MD, PhD
Published: International Symposium on ALS-MND (MNDA)
Date: December 9, 2020
Long-Term Survival of Participants in the CENTAUR Trial of Sodium Phenylbutyrate-Taurursodiol in Amyotrophic Lateral Sclerosis
Lead Author: Sabrina Paganoni, MD, PhD
Published: Muscle & Nerve
Date: October 16, 2020
Long-Term Treatment with AMX0035 in the Open-Label Extension of CENTAUR, a Randomized Controlled Trial in Individuals with Amyotrophic Lateral Sclerosis
Lead Author: Sabrina Paganoni, MD, PhD
Published: American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM)
Date: October 10, 2020
Accurate Testing of Limb Isometric Strength (ATLIS™) for Measuring Muscle Strength in Amyotrophic Lateral Sclerosis: Results from the CENTAUR Trial
Lead Author: Sabrina Paganoni, MD, PhD
Published: American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM)
Date: October 9, 2020
Functional and Long-Term Survival Benefit of AMX0035 in ALS
Lead Author: Sabrina Paganoni, MD, PhD
Published: Northeast ALS Consortium Annual Meeting (NEALS)
Date: September 30, 2020